echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Song Mingke's research group at Shanghai Jiaotong University proposes a new biomarker for Alzheimer's disease

    Song Mingke's research group at Shanghai Jiaotong University proposes a new biomarker for Alzheimer's disease

    • Last Update: 2021-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Alzheimer's disease (Alzheimer's Disease, AD) early biomarkers not only contribute to the early recognition of AD, but also can be used as new drug targets and pharmacodynamic evaluation indicators


    Age is the main risk factor for AD


    Because AEP is widely present in the brain and liver, kidney, pancreas, spleen and other organs, the content of AEP in peripheral body fluids cannot reflect the changes of AEP in the brain.


    Three master students including Wang Shanshan of Shanghai Jiaotong University School of Medicine are the co-first authors of the paper.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.